Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer

NCT03679338•Institut Paoli-Calmettes

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Nonresectable Bile Duct Cancer

Interventions

Ablation Therapy

Locations

France

Locations (1)

Institut Paoli-Calmettes

Marseille, France

Key Dates

Start Date

March 22, 2018

Primary Completion Date

March 18, 2021

Completion Date

March 11, 2022

Last Updated

June 23, 2023

Sponsors

Lead Sponsor

Institut Paoli-Calmettes

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 23, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions